Not yet recruiting
Obesity
Not yet recruitingInvestigational
KAI-9531 in Adults With Obesity or Overweight and Diabetes
Investigational
Countries:
Poland
Poland- Participants:18–64 years · 65+ years
- Substances:HRS 9531
Find therapies in clinical trials near you – page 4
- recruiting
- 3 962
- countries
- 28
- conditions
- 2 101
3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today
93 trials match your criteria
Not yet recruiting
Psoriatic arthropathy
Not yet recruitingInvestigationalNo placebo
A study to evaluate the long-term safety and effectiveness of sonelokimab in patients with psoriatic arthritis
InvestigationalNo placebo
- Disease:Psoriatic arthropathy
- Substances:Sonelokimab
Countries:Poland
Poland- Participants:18–64 years · 65+ years
- Substances:Sonelokimab
Not yet recruiting
Arteriosclerosis
Not yet recruitingInvestigational
Study of Olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
Investigational
- Disease:Arteriosclerosis
- Substances:–
Countries:Poland
Poland- Participants:18–64 years · 65+ years
Not yet recruiting
Metapneumovirus infection
Not yet recruitingInvestigational
Study on the Effectiveness and Safety of IVX-A12 Vaccine for Preventing Respiratory Infections in Adults Aged 60 and Older
Investigational
- Disease:Metapneumovirus infection
- Substances:HUMAN METAPNEUMOVIRUS, VIRUS-LIKE PROTEIN
Countries:Poland
Poland- Participants:18–64 years · 65+ years · Healthy volunteers
- Substances:HUMAN METAPNEUMOVIRUS, VIRUS-LIKE PROTEIN
Not yet recruiting
Crohn's disease
Not yet recruitingInvestigational
Efficacy and safety of ontunisertib in patients with fibrostenosing Crohn’s disease: a phase 2b randomized, double‑blind, placebo‑controlled dose‑ranging trial
Investigational
- Disease:Crohn's disease
- Substances:ORG-129
Countries:Poland
Poland- Participants:18–64 years · 65+ years
- Substances:ORG-129
Not yet recruiting
Coronary artery disease
Not yet recruitingInvestigational
Safety and Pharmacodynamic Study of Subcutaneous RBD1119 in Adults with Coronary Artery Disease
Investigational
- Disease:Coronary artery disease
- Substances:–
Countries:Poland
Poland- Participants:18–64 years · 65+ years
Not yet recruiting
Rheumatoid arthritis
Not yet recruitingRegistered drugNo placebo
Study comparing MB04 (etanercept biosimilar) with Enbrel in patients with moderate to severe rheumatoid arthritis who are taking methotrexate
Registered drugNo placebo
- Disease:Rheumatoid arthritis
- Substances:Etanercept
Countries:Poland
Poland- Participants:18–64 years · 65+ years
- Substances:Etanercept
Not yet recruiting
Colitis ulcerative
Not yet recruitingInvestigational
Study on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
Investigational
- Disease:Colitis ulcerative
- Substances:Obefazimod
Countries:Poland
Poland- Participants:0–17 years · 18–64 years · 65+ years
- Substances:Obefazimod
Not yet recruiting
Colitis ulcerative
Not yet recruitingInvestigational
Study on the Effectiveness of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
Investigational
- Disease:Colitis ulcerative
- Substances:Obefazimod
Countries:Poland
Poland- Participants:0–17 years · 18–64 years · 65+ years
- Substances:Obefazimod
Not recruiting
Gastrooesophageal reflux disease+1
Not recruitingRegistered drug
Study of linaprazan glurate and lansoprazole to maintain healing in patients with erosive esophagitis caused by acid reflux disease
Registered drug
- Disease:Gastrooesophageal reflux diseaseErosive oesophagitis
- Substances:LansoprazoleLINAPRAZAN GLURATE
Countries:Poland
Poland- Participants:18–64 years · 65+ years
- Substances:Lansoprazole
Not recruiting
Arteriosclerosis
Not recruitingInvestigational
A study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)
Investigational
- Disease:Arteriosclerosis
- Substances:–
Countries:Poland
Poland- Participants:18–64 years · 65+ years
Not recruiting
Cardiovascular disorder
Not recruitingInvestigational
A study testing cagrilintide and semaglutide for heart safety in people with cardiovascular disease
Investigational
- Disease:Cardiovascular disorder
- Substances:CagrilintideSemaglutide
Countries:Poland
Poland- Participants:18–64 years · 65+ years
- Substances:Cagrilintide